Cell proliferation and cell loss in nodule-in-nodule hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 46, Issue 26, 1999, Pages 813-819

  Yamamoto, Kazuharu ^a   Takenaka, Kenji ^a   Kajiyama, Kiyoshi ^a   Shimada, Mitsuo ^a   Shirabe, Ken ^a   Taketomi, Akinobu ^a   Maeda, Takashi ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell loss; Cell proliferation; Nodule in nodule hepatocellular carcinoma; Tumor progression

Indexed keywords

FAS ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ANTIGEN EXPRESSION; ARTICLE; CELL KINETICS; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LABELING INDEX; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LIVER; LIVER NEOPLASMS; MITOTIC INDEX; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032905047     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1 Nowel PC: Mechanism of tumor progression. Cancer Res 1986; 46:2203-2207.
2. 2 Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993; 53:2884-2887.
3. 3 Cohen C, DeRose PB: Immunohistochemical p53 in hepatocellular carcinoma and liver dysplasia. Modern Pathol 1994; 7:536-539.
4. 4 Zhao M, Zhang NX, Economou M, Blaha I, Laissue JA, Zimmermann A: Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25:237-245.
5. 5 Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994; 144:460-465.
6. 6 Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55:237-241.
7. 7 Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W: DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990; 50:5127-5135.
8. 8 Farber E: Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Dig Dis Sci 1991; 36:973-978.
9. 9 Zerban H, Radig S, Kopp-Schneider A, Bannasch P: Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis 1994; 15:2467-2473.
10. 10 Kerr JFR, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73:2013-2026.
11. 11 Kojiro M, Sugihara S, Nakashima O: Pathomorphologic characteristics of early hepatocellular carcinoma. Gann Monograph on Cancer Reserch 1991; 38:29-37.
12. 12 Dragan YP, Sargent L, Xu YD, Xu YH, Pitot HC: The initiation-promotion-progression model of rat hepatocarcinogenesis. P Soc Exp Biol Med 1993; 202:16-24.
13. 13 Matsuno Y, Hirohashi S, Furuya S, Sakamoto M, Mukai K, Shimosato Y: Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma. Jpn J Cancer Res 1990; 81:1137-1140.
14. 14 Taniai M, Tomimatsu M, Okuda H, Saito A, Obata H: Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: relationship to histological grade. J Gastroenterol Hepatol 1993; 8:420-425.
15. 15 Aoki K, Sakamoto M, Hirohashi S: Nucleolar organizer regions in small nodular lesions representing early stages of human hepatocarcinogenesis. Cancer 1994; 73:289-293.
16. 16 Oda T, Tsuda H, Sakamoto M, Hirohashi S: Different mutations of the p53 genes in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression. Cancer Lett 1994; 83:197-200.
17. 17 Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462-503.
18. 18 Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T: Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994; 74:1921-1926.
19. 19 Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M: MIB1 staining index and scoring of histologic features in meningioma. Cancer 1994; 74:3176-3189.
20. 20 Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T: Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatol 1994; 19:1354-1359.
21. 21 Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
22. 22 Adachi E, Hashimoto H, Tsuneyoshi M: Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell dysplasia. Cancer 1993; 72:2902-2909.
23. 23 Washington K, Lane KL, Meyers WC: Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol 1993; 17:1151-1158.
24. 24 Holmgren L, O'Reilly MS, Folkmann J: Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1995; 1:149-153.
25. 25 Lowe S, Jacks T, Honsman D, Rulery H: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994; 91:2026-2030.
26. 26 Wang Y, Szekely L, Okan I, Klein G, Wiman RG: Wild type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma cell line. Oncogene 1993; 8:3427-3431.
27. 27 Lotem J, Sachs L: Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemia cells. Cell Growth Differ 1993; 3:41-47.
28. 28 Halder S, Negrini M, Monna M, Sabbioni S, Croce C: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994; 54:2095-2097.
29. 29 Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-243.